Skip navigation links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases

ICEID 2002





   Plenary Sessions
   Invited Panels
   Slide Sessions
   Meet the Experts and First Encounters
   A-Z Listing by Speakers
   A-Z Listing by Presentation Title
   A-Z Listing by Major Topic
   A-Z Listing by Agent or Disease
 Continuing Education Credits
 Organizing Committee

ICEID 2000

International Conference on Emerging Infectious Diseases
ICEID Home Contact Us

ICEID 2002 Webcast
Sessions by Day

 Tuesday, March 26
Panel Sessions 

International Health

  • CDC-PAHO Collaboration: Surveillance of Emerging/Reemerging Diseases in the Amazon and the Southern Cone Region
    Gabriel Schmunis, Pan American Health Organization, Washington, DC
  • Protecting the Nation's Health in an Era of Globalization: CDC's Global Infectious Disease Strategy
    Scott Dowell, CDC, Atlanta, GA
  • Update on the WHO Global Alert and Response Network
    Ray Arthur, WHO, Geneva, Switzerland
Plenary Session III
  • Foot and Mouth Disease
    Christopher Bostock, Institute of Animal Health, Compton, United Kingdom
  • Integrated Surveillance and Control of Emerging Foodborne Diseases—The Successful Danish Experience
    Henrik Wegener, Danish Zoonosis Institute, Denmark
Plenary Session IV 
  • New Strategies on the Old Ideas: Malaria Control Without Insecticides and Community Participation in Aedes aegypti Control, Mexico's Experiences
    Jorge F. Méndez-Galván, Ministry of Health, Mexico City, Mexico
  • Trypanosomiasis as a Reemerging Infection
    Anne Moore, CDC, Atlanta, GA
Bring Your Lunch 

First Encounters with New Diseases: The Clinician's Perspective

  • AIDS
    Michael Gottlieb, Los Angeles, CA
  • Hantavirus Pulmonary Syndrome
    Bruce Tempest, Gallup, NM
  • West Nile Virus Infection
    Deborah Asnis, Brooklyn, NY
Panel Sessions 

Anthrax 2001: Lessons that Stunned Us

  • Anthrax in the U.S. Postal System
    Michele Pearson, CDC, Atlanta, GA
  • Cutaneous Anthrax in New York City
    Marcelle Layton, New York Department of Health, New York, NY
  • Inhalation Anthrax in Florida
    Steve Wiersma, Florida Department of Health, Tallahassee, FL
  • Inhalation Anthrax of Unknown Source
    James Hadler, Connecticut Department of Public Health, Hartford, CT

Emerging Issues in Healthcare Settings

  • Controlling Antimicrobial Resistance
    Barry Farr, University of Virginia Hospital, Charlottesville, VA
  • Patient Safety: Applying Industrial Quality Models in Healthcare Settings to Improve Outcomes
    Julie Gerberding, CDC, Atlanta, GA
  • Prevention of Intravascular Catheter-Related Infections
    Leonard Mermel, Rhode Island Hospital, Providence, RI
  • The Role of Healthcare Systems in Bioterrorism Preparedness
    Trish Perl, Johns Hopkins Hospital, Baltimore, MD

Pathogen Discovery

  • Clusters of Clinical Syndromes in Patients with Unexplained Encephalitis
    Carol Glaser, California Department of Health Services, Berkeley, CA
  • Proteomics and Pathogen Discovery
    Donald Hunt, University of Virginia, Charlottesville, VA
  • The New Human Metapneumovirus
    Albert Osterhaus, University of Rotterdam, Rotterdam, The Netherlands
  • Multiple Array Technology to Look for mRNA Patterns Associated with Disease and Pathogens
    David Relman, Stanford University, Stanford, CA

Preventing Infectious Disease Through Behavioral Change

  • Bringing Dengue Prevention Down to Earth: Evaluation of a Head Start Project in Puerto Rico
    Carmen Pérez-Guerra, CDC, San Juan, PR
  • Increasing Water Vessel Use in Kenya
    Philip Makutsa, CARE International in Kenya, Homa Bay, Kenya
  • Sex Workers as Targets of and Agents for HIV/STI Prevention
    Rafael Mazin, Pan American Health Organization HCA/HCP, Washington, DC
  • The Essential Role of Behavioral and Social Sciences in the Prevention of Emerging Infectious Diseases
    Emily Zielinski-Gutiérrez, CDC, Fort Collins, CO

The World and Its Moving Parts: Implications for Emerging Infectious Diseases

  • Emerging Vectorborne Disease: The Case of Yellow Fever
    C.J. Peters, University of Texas, Medical Branch, Galveston, TX
  • Global Migration and Emerging Infectious Diseases
    Daniele Grondin, International Organization for Migration, Geneva, Switzerland
  • The Globalization of Our Food Supply: Implications for Emerging Infections
    Michael Osterholm, University of Minnesota Academic Health Center, Minneapolis, MN
  • The World and Its Moving Parts: An Overview
    Martin Cetron, CDC, Atlanta, GA
Slide Sessions 

Antimicrobial Resistance II

  • Antimicrobial Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
    J.K. Varma, CDC, Atlanta, GA
  • Antimicrobial Resistance in Salmonella Serotype Typhimurium, R-Type ACSSuT, is Associated with Bacteremia: NARMS 1996-2000
    Kare Molbak, Statens Serum Institut, Copenhagen, Denmark
  • Emerging Fluoroquinolone Resistance among Non-Typhoidal Salmonella in the United States: NARMS 1996-2000
    Shannon Rossiter, CDC, Atlanta, GA
  • Prevalence of Salmonella spp. and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in Broilers and Swine in Denmark
    Mary Evans, Danish Veterinary Institute, Copenhagen, Denmark
  • Quinupristin/Dalfopristin-Resistant Enterococcus faecium Isolated from Human Stools, Retail Chicken, and Retail Pork: EIP Enterococci Project
    Kathryn Gay, CDC, Atlanta, GA
  • Randomized Trial of Day Care Staff Education to Improve Parent Knowledge and Attitudes Regarding Appropriate Antibiotic Use
    Donita Croft, Wisconsin Division of Public Health and CDC, Madison, WI

Emerging Zoonoses II

  • A Neighborhood Outbreak of Q Fever Linked to a Goat Ranch in California
    Michele Jay, California Department of Health Services, Sacramento, CA
  • Clinical Management and Outcomes of Lyme Disease in Wisconsin
    Daniel O'Leary, CDC, Fort Collins, CO
  • Emerging Rickettsioses of the Thai-Myanmar Border
    Philippe Parola, Harvard School of Public Health, Boston, MA
  • Emerging Zoonoses: A Novel Epizootic of Skunks Infected with a Bat Variant of Rabies
    Mira Leslie, Arizona Department of Health Services, Phoenix, AZ
  • Epidemiology of Raccoon and Skunk Rabies in the Eastern United States
    Marta Guerra, CDC, Atlanta, GA
  • Q Fever in the United States: Experience of Infectious Disease Consultants and Comparison to National Reporting During 2000
    Jennifer McQuiston, CDC, Atlanta, GA

Foodborne and Waterborne Illness II

  • Yersinia enterocolitica Surveillance in Minnesota
    Joni Scheftel, Minnesota Department of Health, Minneapolis, MN
  • Epidemiology of Shiga Toxin-Producing Escherichia coli (STEC) Infections in Connecticut, February 1, 2000-January 31, 2001
    Q. Phan, Connecticut Department of Public Health, Hartford, CT
  • Microbiologic Testing to Identify Shiga Toxin-Producing E. coli in HUS Patients: FoodNet 1997-2001
    C.R. Braden, CDC, Atlanta, GA
  • Re-estimating the Global Burden of Typhoid Fever
    John Crump, CDC, Atlanta, GA
  • Risk Factors for Sporadic Escherichia coli O157 Infections in the United States: A Case-Control Study in FoodNet Sites, 1999-2000
    M.H. Kennedy, CDC, Atlanta, GA
  • Three Outbreaks of E. coli O157 Infections Due to Retail Ground Beef in Minnesota, 2000: Detection, Investigation, and Characteristics
    Ellen Swanson, Minnesota Department of Health, Minneapolis, MN

Prevention and Control Strategies

  • Active Laboratory Surveillance in Massachusetts
    Bela Matyas, Massachusetts Department of Public Health, Jamaica Plain, MA
  • An Evaluation of an Educational Videotape to Prevent Botulism among Alaska Natives
    Catherine Dentinger, CDC, Anchorage, AK
  • Evidence of Effectiveness of Egg Quality Assurance Programs, Mandatory Refrigeration, and Traceback Investigations to Mitigate Egg-Associated Salmonella enteritidis Infections in the United States
    Gerald Mumma, CDC, Atlanta, GA
  • Improving Influenza and Pneumococcal Vaccination Rates for People 65+ in Rhode Island through Coalition Building Efforts
    Thomas Bertrand, Rhode Island Department of Health, Providence, RI
  • The Emergence of Serogroup Y Disease and the Epidemiology of Invasive Meningococcal Disease in Colorado, 1997-2001
    Lucinda Hammond, Colorado Department of Public Health and Environment, Denver, CO
  • Transmission of the Main Viral Pathogens Causing Gastroenteritis, NLV, SLV, and Rotavirus
    Yvonne van Duynhoven, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Vectorborne Diseases II

  • In vivo Sensitivity of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine During an Outbreak of Malaria in Burundi, 2001
    François Dantoine, Epicentre, Paris, France
  • A Greenhouse Study to Model Potential Field Use of Genetically Modified Bacterial Symbionts for Chagas' Disease Control
    Pritha Sen, CDC, Atlanta, GA
  • Dengue Fever Outbreak in Hawaii—2001
    Paul Effler, State of Hawaii Department of Health, Honolulu, HI
  • Ecological Niche Modeling and Differentiation of Populations of Triatoma Brasiliensis Neiva, 1911, the Most Important Chagas Disease Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
    Jane Costa, CDC, Atlanta, GA
  • Re-introduction of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological and Laboratory Features of a New Outbreak
    Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo, Maracay, Venezuela
  • Risk Factors for Lyme Borreliosis: A German Case-Control Study
    Andrea Ammon, Robert Koch Institute, Berlin, Germany
Slide Sessions 

Global Health and GIS

  • A WHO Global Salm-Surv Retrospective Study Examining Salmonella Serotypes in South America, 2000: Dominance of Salmonella Serotype Enteritidis
    WHO Global Salm-Surv South America Working Group, Instituto INEI-ANLIS "Carlos G. Malbran", Buenos Aires, Argentina
  • Investigation of Q Fever in Bosnia-Herzegovina, 2000: An Example of International Cooperation
    Jennifer McQuiston, CDC, Atlanta, GA
  • Mapping of West Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
    P. Bryon Backenson, New York State Department of Health, Albany, NY
  • Modeling Tuberculosis Dissemination in Harris County, Texas, 1995-1998, with Spatial Analysis and Geographic Information Systems (GIS)
    Matthew Stone, University of Texas-Houston, Houston, TX
  • Recurrent Histoplasmosis Outbreaks in Acapulco, Mexico
    Yuri Roldán-Aragón, National Institute of Medical Science and Nutrition, Mexico City, Mexico


  • A DoD Global Influenza Surveillance Program
    Linda Canas, Brooks Air Force Base, San Antonio, TX
  • Acute Respiratory Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June 2001
    Diaa Salman, U.S. Naval Medical Research Unit No 3., Cairo, Egypt
  • Geographical Coherence of Influenza Epidemics in the U.S., France, and Australia: 1978-1998
    Cecile Viboud, INSERM U444, Paris cedex 12, France
  • Influenza Surveillance in New York State, 1998-2001
    Marilyn Kacica, New York State Department of Health, Albany, NY
  • PER.C6: A Human Designer Cell Line Providing a Pandemic-Proof Platform for the Manufacturing of Safe Influenza Vaccines
    Fons UytdeHaag, Crucell Holland BV, Leiden, The Netherlands
  • Using CUSUM Techniques to Identify Influenza Outbreaks
    Michael Stoto, The Rand Corporation, Arlington, VA

Latebreakers II

  • An Anthrax Outbreak Averted: Public Health Response to a Contaminated Envelope on Capitol Hill, Washington, DC, 2001
    V.P. Hsu, CDC, Atlanta, GA
  • Bioterrorism 2001: Lessons Learned
    L.A. Cole, Rutgers University, Newark, NJ
  • Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
    A. Hoffmaster, CDC, Atlanta, GA
  • Inhalational Anthrax—New York City, October-November 2001
    T.H. Holtz, New York City Department of Health, New York, NY
  • Letters from Trenton: The Anthrax Investigation at the Source, New Jersey, 2001
    J. Reefhuis, CDC, Atlanta, GA
  • Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October-December, 2001
    C.M. Greene, CDC, Atlanta, GA

Molecular Diagnostics and Epidemiology II

  • Detection of La Crosse Virus in Cerebrospinal Fluid and Tissues by Reverse Transcription-Polymerase Chain Reaction
    Brett Slater, New York State Department of Health, Slingerlands, NY
  • Determination of Allelic Diversity in the mec Operon of Methicillin-Resistant Staphylococcus aureus in Wisconsin
    Sanjay Shukla, Marshfield Medical Research Foundation, Marshfield, WI
  • Development and Evaluation of PCR-Based Diagnostics for Identification of Salmonella O Antigens Based on the rfb Locus
    Collette Fitzgerald, CDC, Atlanta, GA
  • Molecular Characterization of a Multiresistant Strain of Salmonella enterica serotype Typhimurium DT204b Responsible for an International Outbreak of Salmonellosis
    E.J. Threlfall, Central Public Health Laboratory, London, United Kingdom
  • PulseNet Experience: Software Changes and Improvements to Online E. coli National Database
    Susan Hunter, CDC, Atlanta, GA
  • Real-time Fluorescence PCR Assays for the Detection and Characterization of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic Escherichia coli
    Nancy Strockbine, CDC, Atlanta, GA

Surveillance and Information Systems

  • Analysis of a Health Indicator Surveillance System: Its Ability to Detect Annual Influenza Activity for the 1999-2000 and 2000-2001 Seasons Compared to Traditional Surveillance Systems
    Ji-Eun Lee, Department of Defense Global Emerging Infections System, Silver Spring, MD
  • Foodborne Viruses in Europe: Web-Based Technologies for Investigation of Transnational Outbreaks of Viral Gastroenteritis
    Ben Lopman, Public Health Laboratory Service, London, United Kingdom
  • Lessons Learned from Implementing Electronic Laboratory Reporting, New York State
    Perry Smith, New York State Department of Health, Albany, NY
  • Lyme Disease Incidence in Wisconsin: A Comparison of State Reported Rates with Rates from a Population-Based Cohort
    Allison Naleway, Marshfield Medical Research Foundation, Marshfield, WI
  • Outbreak Surveillance: An Important Tool for Controlling Communicable Diseases
    Michael Baker, ESR, Wellington, New Zealand
  • Surveillance for Patients with Acute Febrile Illness in Egypt
    Salma Afifi, U.S. Naval Medical Research Unit No. 3, Cairo, Egypt

Top of Page

  Top of Page


ICEID Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed April 17, 2002

International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Privacy Policy | Accessibility

 U.S. Department of Health and Human Services (HHS)